Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID‐19 diagnosis
Open Access
- 17 May 2021
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (9), 5650-5654
- https://doi.org/10.1002/jmv.27089
Abstract
The aim of our study was to evaluate the diagnostic performance of two antigen rapid diagnostic tests (Ag-RDTs) to diagnose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We evaluated Panbio and SD-Biosensor Ag-RDTs. We employed 186 polymerase chain reaction (PCR) negative samples to evaluate the specificity and 170 PCR positive samples to assess the sensitivity. We evaluated their sensitivity according to Cycle threshold (Ct) values and days post onset of symptoms (d.p.o.). Tests were compared using the McNemar's test. Agreement was evaluated using the kappa score. Specificity was 100% for Panbio and 97.3% for SD-Biosensor. Sensitivity for samples with Ct ≤ 20 was 100% for both assays and for samples with Ct = 20–25 was 93.0% (Panbio) and 95.3% (SD-Biosensor) (p = 1.000). Sensitivity decreased for samples wit Ct = 25–30 (Panbio: 41.3%, SD-Biosensor: 52.2%, p = 0.125) and samples with Ct ≥ 30 (Panbio: 5.0%, SD-Biosensor: 17.5%, p = 0.063). Sensitivity within seven d.p.o. was 87.7% for Panbio and 90.4% for SD-Biosensor and notably decreased after seven d.p.o. Agreement with PCR was excellent for high viral load samples (Ct ≤ 25): Panbio, 98.9%, kappa = 0.974; SD-Biosensor, 97.4%, kappa = 0.940. Agreement between Ag-RDTs was excellent (94.9%, kappa = 0.882). Panbio and SD-Biosensor Ag-RDTs showed excellent agreement and diagnostic performance results for samples with high viral loads (Ct ≤ 25) or samples within seven d.p.o.This publication has 17 references indexed in Scilit:
- Rethinking Covid-19 Test Sensitivity — A Strategy for ContainmentThe New England Journal of Medicine, 2020
- Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of KoreaJAMA Internal Medicine, 2020
- Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptomsJournal of Clinical Virology, 2020
- Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2Journal of Clinical Virology, 2020
- Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infectionEmergencias, 2020
- Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal SwabsJournal of Clinical Microbiology, 2020
- Evaluation of rapid antigen test for detection of SARS-CoV-2 virusJournal of Clinical Virology, 2020
- Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic ContextFrontiers in Medicine, 2020
- In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging TrendsDiagnostics, 2020
- Interrater reliability: the kappa statistic2012